IO Biotech

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IO Biotech and other ETFs, options, and stocks.

About IOBT

IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms.

CEO

Mai-Britt Zocca

CEOMai-Britt Zocca

Employees

Employees80

Headquarters

Copenhagen, North Denmark

HeadquartersCopenhagen, North Denmark

Founded

2014

Founded2014

Employees

Employees80

IOBT Key Statistics

Market cap

62.12M

Market cap62.12M

Price-Earnings ratio

-0.64

Price-Earnings ratio-0.64

Dividend yield

—

Dividend yield—

Average volume

80.07K

Average volume80.07K

High today

$1.00

High today$1.00

Low today

$0.85

Low today$0.85

Open price

$0.93

Open price$0.93

Volume

213.60K

Volume213.60K

52 Week high

$1.79

52 Week high$1.79

52 Week low

$0.66

52 Week low$0.66

IO Biotech

Why Robinhood?

IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. Show more

IOBT Key Statistics

IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms.